Cooper PE Ratio 2010-2024 | COO
Current and historical p/e ratio for Cooper (COO) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cooper PE ratio as of April 25, 2024 is 27.05.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Cooper PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-04-26 |
88.84 |
|
60.75 |
| 2024-01-31 |
23.31 |
$1.46 |
15.94 |
| 2023-10-31 |
19.48 |
$1.48 |
13.19 |
| 2023-07-31 |
24.45 |
$1.38 |
17.69 |
| 2023-04-30 |
23.84 |
$1.45 |
16.44 |
| 2023-01-31 |
21.81 |
$1.89 |
11.55 |
| 2022-10-31 |
17.08 |
$1.94 |
8.81 |
| 2022-07-31 |
20.43 |
$2.16 |
9.45 |
| 2022-04-30 |
22.56 |
$4.76 |
4.74 |
| 2022-01-31 |
24.89 |
$4.71 |
5.28 |
| 2021-10-31 |
26.05 |
$14.81 |
1.76 |
| 2021-07-31 |
26.35 |
$14.67 |
1.80 |
| 2021-04-30 |
25.67 |
$11.86 |
2.16 |
| 2021-01-31 |
22.74 |
$11.33 |
2.01 |
| 2020-10-31 |
19.93 |
$1.20 |
16.57 |
| 2020-07-31 |
17.67 |
$1.40 |
12.65 |
| 2020-04-30 |
17.91 |
$1.72 |
10.43 |
| 2020-01-31 |
21.67 |
$2.27 |
9.53 |
| 2019-10-31 |
18.18 |
$2.34 |
7.78 |
| 2019-07-31 |
21.07 |
$2.24 |
9.43 |
| 2019-04-30 |
18.11 |
$2.14 |
8.45 |
| 2019-01-31 |
17.41 |
$1.84 |
9.47 |
| 2018-10-31 |
16.13 |
$0.70 |
23.21 |
| 2018-07-31 |
16.27 |
$0.64 |
25.62 |
| 2018-04-30 |
14.28 |
$0.65 |
21.97 |
| 2018-01-31 |
15.28 |
$0.87 |
17.51 |
| 2017-10-31 |
15.00 |
$1.88 |
7.98 |
| 2017-07-31 |
15.22 |
$1.74 |
8.74 |
| 2017-04-30 |
12.51 |
$1.67 |
7.50 |
| 2017-01-31 |
11.52 |
$1.52 |
7.59 |
| 2016-10-31 |
10.99 |
$1.40 |
7.86 |
| 2016-07-31 |
11.39 |
$1.28 |
8.91 |
| 2016-04-30 |
9.55 |
$1.06 |
9.03 |
| 2016-01-31 |
8.18 |
$0.99 |
8.31 |
| 2015-10-31 |
9.51 |
$1.04 |
9.18 |
| 2015-07-31 |
11.04 |
$1.01 |
10.99 |
| 2015-04-30 |
11.11 |
$1.23 |
9.05 |
| 2015-01-31 |
9.83 |
$1.33 |
7.42 |
| 2014-10-31 |
10.22 |
$1.38 |
7.41 |
| 2014-07-31 |
10.03 |
$1.51 |
6.64 |
| 2014-04-30 |
8.22 |
$1.51 |
5.46 |
| 2014-01-31 |
7.75 |
$1.48 |
5.23 |
| 2013-10-31 |
8.05 |
$1.49 |
5.41 |
| 2013-07-31 |
7.94 |
$1.57 |
5.06 |
| 2013-04-30 |
6.88 |
$1.46 |
4.71 |
| 2013-01-31 |
6.32 |
$1.36 |
4.64 |
| 2012-10-31 |
5.98 |
$1.27 |
4.73 |
| 2012-07-31 |
4.69 |
$1.19 |
3.95 |
| 2012-04-30 |
5.49 |
$1.04 |
5.27 |
| 2012-01-31 |
4.49 |
$0.95 |
4.75 |
| 2011-10-31 |
4.31 |
$0.91 |
4.77 |
| 2011-07-31 |
4.76 |
$0.88 |
5.44 |
| 2011-04-30 |
4.66 |
$0.90 |
5.21 |
| 2011-01-31 |
3.57 |
$0.74 |
4.84 |
| 2010-10-31 |
3.07 |
$0.61 |
5.05 |
| 2010-07-31 |
2.42 |
$0.52 |
4.69 |
| 2010-04-30 |
2.42 |
$0.42 |
5.75 |
| 2010-01-31 |
2.20 |
$0.53 |
4.14 |
| 2009-10-31 |
1.74 |
$0.55 |
3.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.874B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
